Metabolic profiling in Prader-Willi syndrome and nonsyndromic obesity: Sex differences and the role of growth hormone

Clinical Endocrinology

Volumn 83, Issue 6, 2015, Pages 797-805

  Irizarry, Krystal A ^a   Bain, James ^a,b   Butler, Merlin G ^c   Ilkayeva, Olga ^b   Muehlbauer, Michael ^b   Haqq, Andrea M ^d   Freemark, Michael ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; ADIPOCYTOKINE; ADIPONECTIN; AMINO ACID; ARGININE; ASPARAGINE; ASPARTIC ACID; CITRULLINE; FATTY ACID; GHRELIN; GLUTAMIC ACID; GLUTAMINE; GLYCINE; GROWTH HORMONE; INSULIN; LEPTIN; MEPYRAMINE MALEATE; PEPTIDE YY; SERINE; TYROSINE; ADIPOQ PROTEIN, HUMAN;

AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOOD INTAKE; HUMAN; HYPERPHAGIA; HYPOINSULINEMIA; INSULIN SENSITIVITY; MALE; OBESITY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; SEX DIFFERENCE; UPREGULATION; WEIGHT GAIN; ADOLESCENT; BLOOD; COMPLICATION; METABOLISM; PRADER-WILLI SYNDROME;

ADIPONECTIN; ADOLESCENT; CHILD; FASTING; FEMALE; GHRELIN; GROWTH HORMONE; HUMANS; INSULIN; LEPTIN; MALE; OBESITY; PEPTIDE YY; PRADER-WILLI SYNDROME;

EID: 84961336825     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12766     Document Type: Article

References (36)

1. Cassidy, S.B., Dykens, E., &, Williams, C.A., (2000) Prader-Willi and angelman syndromes: sister imprinted disorders. American Journal of Medical Genetics, 97, 137-146.
2. Butler, M.G., (2011) Prader-Willi syndrome: obesity due to genomic imprinting. Current Genomics, 12, 204-215.
3. Emerick, J., &, Vogt, K., (2013) Endocrine manifestations and management of Prader-Willi syndrome. International Journal of Pediatric Endocrinology, 2013, 14.
4. Haqq, A.M., Grambow, S.C., Muehlbauer, M., et al,. (2008) Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clinical Endocrinology, 69, 911-920.
5. Prodam, F., Monzani, A., Ricotti, R., et al,. (2014) Systematic review of ghrelin response to food intake in pediatric age, from neonates to adolescents. The Journal of Clinical Endocrinology & Metabolism, 99, 1556-1568.
6. Wren, A.M., Seal, L.J., Cohen, M.A., et al,. (2001) Ghrelin enhances appetite and increases food intake in humans. The Journal of Clinical Endocrinology & Metabolism 86, 5992-5995.
7. Tschop, M., Smiley, D.L., &, Heiman, M.L., (2000) Ghrelin induces adiposity in rodents. Nature, 407, 908-913.
8. Batterham, R.L., &, Bloom, S.R., (2003) The gut hormone peptide YY regulates appetite. Annals of the New York Academy of Sciences, 994, 162-168.
9. Stock, S., Leichner, P., Wong, A.C.K., et al,. (2005) Ghrelin, Peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. The Journal of Clinical Endocrinology & Metabolism, 90, 2161-2168.
10. Nass, R., Gaylinn, B.D., &, Thorner, M.O., (2011) The role of ghrelin in GH secretion and GH disorders. Molecular and Cellular Endocrinology, 340, 10-14.
11. Bartz, S., Mody, A., Hornik, C., et al,. (2014) Severe acute malnutrition in childhood: hormonal and metabolic status at presentation, response to treatment, and predictors of mortality. The Journal of Clinical Endocrinology & Metabolism, 99, 2128-2137.
12. Li, R.L., Sherbet, D.P., Elsbernd, B.L., et al,. (2012) Profound hypoglycemia in starved, ghrelin-deficient mice is caused by decreased gluconeogenesis and reversed by lactate or fatty acids. Journal of Biological Chemistry, 287, 17942-17950.
13. Haqq, A.M., Farooqi, I.S., O'Rahilly, S., et al,. (2003) Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 88, 174-178.
14. Feigerlová, E., Diene, G., Conte-Auriol, F., et al,. (2008) Hyperghrelinemia precedes obesity in Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 93, 2800-2805.
15. Kweh, F.A., Miller, J.L., Sulsona, C.R., et al,. (2014) Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia. American Journal of Medical Genetics Part A 167, 69-79.
16. Haqq, A.M., Muehlbauer, M., Svetkey, L.P., et al,. (2007) Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clinical Endocrinology, 67, 944-951.
17. Muniyappa, R., Lee, S., Chen, H., et al,. (2008) Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. American Journal of Physiology-Endocrinology and Metabolism, 294, E15-E26.
18. Newgard, C.B., An, J., Bain, J.R., et al,. (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metabolism, 9, 311-326.
19. Newbern, D., Gumus Balikcioglu, P., Balikcioglu, M., et al,. (2014) Sex differences in biomarkers associated with insulin resistance in obese adolescents: metabolomic profiling and principal components analysis. The Journal of Clinical Endocrinology & Metabolism, 99, 4730-4739.
20. Patterson, B.W., Zhao, G., Elias, N., et al,. (1999) Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. Journal of Lipid Research, 40, 2118-2124.
21. Goldstone, A.P., Patterson, M., Kalingag, N., et al,. (2005) Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma. The Journal of Clinical Endocrinology & Metabolism, 90, 2681-2690.
22. Butler, M.G., Bittell, D.C., &, Talebizadeh, Z., (2004) Plasma peptide YY and ghrelin levels in infants and children with Prader-Willi syndrome. Journal of Pediatric Endocrinology and Metabolism, 17, 1177-1184.
23. Haqq, A.M., Muehlbauer, M.J., Newgard, C.B., et al,. (2011) The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. The Journal of Clinical Endocrinology & Metabolism, 96, E225-E232.
24. Haqq, A.M., DeLorey, D.S., Sharma, A.A., et al,. (2012) Autonomic nervous system dysfunction in obesity and Prader-Willi syndrome: current evidence and implications for future obesity therapies. Clinical Obesity, 1, 175-183.
25. Goldstone, A.P., Thomas, E.L., Brynes, A.E., et al,. (2001) Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution. The Journal of Clinical Endocrinology & Metabolism, 86, 4330-4338.
26. Peplies, J., Jimenez-Pavon, D., Savva, S.C., et al,. (2014) Percentiles of fasting serum insulin, glucose, HbA1c and HOMA-IR in pre-pubertal normal weight European children from the IDEFICS cohort. International Journal of Obesity, 38 (Suppl 2), S39-S47.
27. Laeger, T., Reed, S.D., Henagan, T.M., et al,. (2014) Leucine acts in the brain to suppress food intake but does not function as a physiological signal of low dietary protein. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 307, R310-R320.
28. Drgonova, J., Jacobsson, J.A., Han, J.C., et al,. (2013) Involvement of the neutral amino acid transporter SLC6A15 and leucine in obesity-related phenotypes. PLoS ONE, 8, e68245.
29. Tai, E.S., Tan, M.L.S., Stevens, R.D., et al,. (2010) Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men. Diabetologia, 53, 757-767.
30. Butler, M.G., Murrell, J.E., &, Greene, H.L., (1990) Amino acid levels in Prader-Willi syndrome and obese individuals. Dysmorphology and Clinical Genetics, 4, 18-22.
31. Deal, C.L., Tony, M., Höybye, C., et al,. (2013) Growth hormone research society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. The Journal of Clinical Endocrinology & Metabolism, 98, E1072-E1087.
32. Kuromaru, R., Kohno, H., Ueyama, N., et al,. (1999) Long-term effect of growth hormone (GH) treatment on body composition in children with GH deficiency. Endocrine Journal, 46 (Suppl), S35-S38.
33. Aycan, Z., &, Baş, V.N., (2014) Prader-Willi syndrome and growth hormone deficiency. Journal of Clinical Research in Pediatric Endocrinology, 6, 62-67.
34. Feigerlová, E., Diene, G., Oliver, I., et al,. (2010) Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment. The Journal of Clinical Endocrinology & Metabolism, 95, 4600-4608.
35. Lara-Castro, C., Luo, N., Wallace, P., et al,. (2006) Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes, 55, 249-259.
36. Copeland, K.C., &, Nair, K.S., (1994) Acute growth hormone effects on amino acid and lipid metabolism. The Journal of Clinical Endocrinology & Metabolism, 78, 1040-1047.